Promising pulmonary fibrosis treatment on path to clinical trials

A research team at Taiwan's National Yang Ming Chiao Tung University (NYCU) has transferred the technology for its experimental stem cell therapy treatment for pulmonary fibrosis to two biotech companies, in a first step toward beginning clinical trials, it announced Friday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)